General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application

Journal of Clinical Epidemiology

Volumn 60, Issue 10, 2007, Pages 1076.e1-1076.e10

  Stewart, Roy ^a   Niessen, Wim J M ^b   Broer, Jan ^b   Snijders, Tom A B ^c   Haaijer Ruskamp, Floor M ^a   Meyboom De Jong, Betty ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Municipal Public Health Service Groningen   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Benzodiazepine use; Chronic user; General practitioner; Intervention study; Long term prescription; Multilevel modeling

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; HYPNOTIC AGENT;

ADULT; AGED; ARTICLE; DOCTOR PATIENT RELATION; DRUG USE; GENERAL PRACTITIONER; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 34548609503     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2006.11.024     Document Type: Article

References (44)

1. Hollister L.E., Müller-Oerlinghausen B., Rickels K., and Shader R.I. Clinical uses of benzodiazepines. J Clin Psychopharmacol 13 6 Suppl 1 (1993) 1S-169S
2. Longo L.P., and Johnson B. Addiction: Part 1. Benzodiazepines-side effects, abuse risk and alternatives. Am Fam Physician 61 (2000) 2121-2128
3. Nolan L., and O'Malley K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol 35 (1988) 225-229
4. Petrovic M., Mariman A., Warie H., Afschrift M., and Pevernagie D. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg 58 (2003) 1-36
5. Bendtsen P., Hensing G., McKenzie L., and Stridsman A.K. Prescribing benzodiazepines-a critical incident study of a physician dilemma. Soc Sci Med 49 (1999) 459-467
6. van Hulten R., Teeuw K.B., Bakker A.B., Bakker A., and Leufkens H.G. Characteristics of current benzodiazepine users as indicators of differences in physical and mental health. Pharm World Sci 22 3 (2000) 96-101
7. Cormack M.A., Owens R.G., and Dewey M.E. The effect of minimal interventions by general practitioners on long-term benzodiazepine use. J R Coll Gen Pract 39 327 (1989) 408-411
8. Gorgels W., Oude Voshaar R., Mol A., van de Lisdonk E., van Balkom A., van den Hoogen H., et al. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend 78 (2005) 49-56
9. Morgan J.D., Wright D.J., and Chrystyn H. Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepines. Pharm World Sci 24 (2002) 231-235
10. Morrison J.M. Audit and follow-up of chronic benzodiazepine tranquillizer use in one general practice. Fam Pract 7 (1990) 253-257
11. Cormack M.A., Sweeney K.G., Hughes-Jones H., and Foot G.A. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. Br J Gen Pract 44 378 (1994) 5-8
12. Bashir K., King M., and Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Pract 44 386 (1994) 408-412
13. Barker M.J., Greenwood K.M., Jackson M., and Crowe S.F. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 18 (2004) 37-48
14. Simon G.E., Vonkorff M., Barlow W., Pabiniak C., and Wagner E. Predictors of chronic benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 49 (1996) 1067-1073
15. Zandstra S.M., Furer J.W., van de Lisdonk E.H., van't Hof M., Bor J.H.J., van Weel C., et al. Different study criteria affect the prevalence of benzodiazepine use. Soc Psychiatry Psychiatr Epidemiol 37 3 (2002) 139-144
16. Gubbels T.H.C.M., Vissers F.H.J.A., Beusmans G.M.H.I., Kester A.D.M., and Crebolder H.F.J.M. Benzodiazepinegebruik in de huisartspraktijk: waarom laten we het (niet) zo? (Benzodiazepine use in general practice: why do(n't) we change it? An explorative study). Huisarts en Wetenschap 42 3 (1999) 107-111
17. McNutt L., Coles F.B., McAuliffe T., Baird S., Morse D., Strogatz D., et al. Impact of regulation on benzodiazepine prescribing to a low income elderly population, New York state. J Clin Epidemiol 47 (1994) 613-625
18. Brownlee K., Devins G.M., Flanigan M., Fleming J.A.E., Morehouse R., Moscovitch A., et al. Are there gender differences in the prescribing of hypnotic medications for insomnia?. Human Psychopharmacol 18 (2003) 1-73
19. Holden J.D., Hughes I.M., and Tree A. Benzodiazepine prescribing and withdrawal for 3234 patients in 15 general practices. Fam Pract 11 (1994) 358-362
20. Isacson D. Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time-a 13-year follow-up in a Swedish community. Soc Sci Med 44 (1997) 1871-1880
21. van der Waals F.W., and Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. Br Med J 307 6900 (1993) 363-366
22. Bjorner T., and Laerum E. Factors associated with high prescribing of benzodiazepines and minor opiates: a survey among general practitioners in Norway. Scand J Prim Health Care 21 (2003) 2-120
23. Dybwad T.B., Kjolsrod L., Eskerud J., and Laerum E. Why are some doctors high-prescribers of benzodiazepines and minor opiates? A qualitative study of GPs in Norway. Fam Pract 14 (1997) 361-368
24. Pimlott N., Hux J., Wilson L., Kahan M., Li C., and Rosser W. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ 168 (2003) 835-839
25. Multilevel modeling of health statistics (2001), John Wiley & Sons, Ltd, Chichester
26. Duncan C., Jones K., and Moon G. Context, composition and heterogeneity: using multilevel models in health research. Soc Sci Med 46 (1998) 97-117
27. Goldstein H., Browne W.J., and Rasbash J. Multilevel modelling of medical data. Stat Med 21 (2002) 3291-3315
28. Snijders T.A.B., and Bosker R.J. Multilevel analysis. An introduction to basic and advanced multilevel modelling (1999), SAGE Publications Ltd, London
29. Niessen W.J.M., Stewart R.E., Broer J., and Haaijer-Ruskamp F.M. Vermindering van gebruik van benzodiazepinen door een brief van de eigen huisarts aan chronische gebruikers (Reduction in the consumption of benzodiazepines due to a letter to chronic users from their own general practitioner). Ned Tijdschr Geneeskd 149 (2005) 356-361
30. Niessen W.J.M. Ingeslapen? Een onderzoek naar het gebruik van benzodiazepines in Oost-Groningen (1996), Veendam, GGD Oost-Groningen
31. Defined daily dose (DDD). Available at (2005), WHO Collaborating Centre for Drug Statistics Methodology. www.whocc.no
32. ATC index with DDDs (1999), WHO Collaborating Centre for Drug Statistics Methodology, Oslo
33. Maas C., and Snijders T. The multilevel approach to repeated measures for complete and incomplete data. Quality and Quantity 37 (2003) 71-89
34. Littell R.C., Milliken G.A., Stroup W.W., and Wolfinger R.D. SAS system for mixed models. 1st ed. (1996), SAS Institute Inc., North Carolina
35. A user's guide to MLwiN (1998), Multilevel Models Project, London
36. Oude-Voshaar R.C., Gorgels W., Mol A., van Balkom A., Breteler M., van de Lisdonk E., et al. Predictors of relapse after discontinuation of long-term benzodiazepine use by minimal intervention: a 2-year follow-up study. Fam Pract 20 (2003) 370-372
37. van Broekhoven F., Kan C., and Zitman F. Dependence potential of antidepressants compared to benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 26 (2002) 939-943
38. Zandstra S.M., van Rijswijk E., Rijnders C.A.T., van de Lisdonk E.H., Bor J.H.J., van Weel C., et al. Long-term benzodiazepine users in family practice: differences from short-term users in mental health, coping behaviour and psychological characteristics. Fam Pract 21 (2004) 266-269
39. Miyamoto M., Hirata K., Miyamoto T., Iwase T., and Koshikawa C. Hypnotic prescriptions in a university hospital: analysis of data from the computer-ordering system. Psychiatry Clin Neurosci 56 (2002) 305-306
40. Tu K., Mamdani M.M., Hux J.E., and Tu J.B. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc 49 (2001) 1341-1345
41. Gorgels W.J.M.J., Oude Voshaar R.C., Mol A.J.J., van de Lisdonk E.H., van Balkom A.J.L.M., and van den Hoogen H. Discontinuation of long-term benzodiazepine use by sending a letter to users in general practice. In: Oude Voshaar R.C. (Ed). Consecutive treatment strategies to discontinue long-term benzodiazepine use: a systematic evaluation in general practice (2003), University of Nijmegen, Nijmegen
42. Chung K.F., Cheung R.C.H., and Tam J.W.Y. Long-term benzodiazepine users-characteristics, views and effectiveness of benzodiazepine reduction information leaflet. Singapore Med J 40 3 (1999) 1-8
43. Monane M., Matthias D., Nagle B., and Kelly M. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA 280 (1998) 1249-1252
44. Elliott R.A., Woodward M.C., and Oborne C.A. Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Intern Med J 31 (2001) 529-535